Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions.

Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions. J Clin Oncol. 2007 Jun 10; 25(17):2420-5.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.